Scott Bowden is an experienced senior account executive with a robust background in oncology sales and business development. Currently serving at Guardant Health since July 2018, Scott previously held the position of manager for oncology business development at NeoGenomics Laboratories from June 2015 to June 2018. Prior experience includes over 17 years at Merck as an oncology sales specialist and four years at Glaxo Welcome Inc as a territory sales representative, focusing on the oncology market. Scott holds a Bachelor of Arts degree in Political Science and Government from the University of South Florida, which was completed between 1990 and 1992.